4.8 Article

LRP6 mutation in a family with early coronary disease and metabolic risk factors

Journal

SCIENCE
Volume 315, Issue 5816, Pages 1278-1282

Publisher

AMER ASSOC ADVANCEMENT SCIENCE
DOI: 10.1126/science.1136370

Keywords

-

Funding

  1. NHLBI NIH HHS [P50 HL55007] Funding Source: Medline
  2. NIAMS NIH HHS [R01 AR051476-01A1, R01 AR051476-04, R01 AR051476, R01 AR051476-03, R01 AR051476-02] Funding Source: Medline
  3. NICHD NIH HHS [K08 HD041481, K08 HD041481-01] Funding Source: Medline
  4. NIDDK NIH HHS [P01DK68229] Funding Source: Medline

Ask authors/readers for more resources

Coronary artery disease ( CAD) is the leading cause of death worldwide and is commonly caused by a constellation of risk factors called the metabolic syndrome. We characterized a family with autosomal dominant early CAD, features of the metabolic syndrome (hyperlipidemia, hypertension, and diabetes), and osteoporosis. These traits showed genetic linkage to a short segment of chromosome 12p, in which we identified a missense mutation in LRP6, which encodes a co-receptor in the Wnt signaling pathway. The mutation, which substitutes cysteine for arginine at a highly conserved residue of an epidermal growth factor-like domain, impairs Wnt signaling in vitro. These results link a single gene defect in Wnt signaling to CAD and multiple cardiovascular risk factors.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available